AnubisMed

Product NDC

83021-774

11-digit product format

830210774

Labeler code

83021

Product ID

83021-774_eb04d402-e750-6281-e053-2995a90a5ef3

Type

HUMAN OTC DRUG

Nonproprietary name

Aloe Barbadensis Leaf Extract, Propylene Glycol, Cetearyl Ethylhexanoate

Dosage form

CREAM

Route

TOPICAL

Labeler

ANUBIS COSMETICS SL

Application

M016

Marketing category

OTC MONOGRAPH FINAL

Marketing start

2022-10-14

Marketing end

0000-00-00

Substance

1,2-HEXANEDIOL; ALLANTOIN; ALOE VERA LEAF; ARGAN OIL; BUTYLATED HYDROXYTOLUENE; BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES; C12-20 ACID PEG-8 ESTER; CAPRYLYL GLYCOL; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; DECYL OLEATE; FRAGRANCE 13576; GLYCERIN; GRAPE SEED OIL; HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER; IMIDUREA; MEDIUM-CHAIN TRIGLYCERIDES; PROPYLENE GLYCOL; SILICON DIOXIDE; TOCOPHEROL; TROLAMINE; TROPOLONE; WATER

Active strength

0 g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; mL/15mL

Pharmacologic classes

Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]

NDC exclude flag

No

Listing certified through

2023-12-31

Current FDA listing

Historical FDA.report record